52.1 F
New York
HomeMedicine

Medicine

DAVID LETTERMAN RECEIVES GLAUCOMA FOUNDATION’S SPOTLIGHT AWARD

NEW YORK, April 19, 2024 /PRNewswire/ -- Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award.Said TGF Chairman Gregory...

Bone Health and Osteoporosis Foundation Announces Call for Nominees for New Robert F. Gagel, M.D. Community Leadership Award

ARLINGTON, Va., April 19, 2024 /PRNewswire/ -- The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in raising...

Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old

In the United States, the Osia System is now cleared for children ages 5 and older The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD) The Osia System has been...

Annals of Internal Medicine presents breaking scientific news at ACP’s Internal Medicine Meeting 2024

Authors discuss evidence-based research on obesity, antibiotic resistance, and type 2 diabetesBOSTON, April 19, 2024 /PRNewswire/ -- Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured...

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

Reviews evidence of newer medications, recommends adding to metforminBOSTON, April 19, 2024 /PRNewswire/ -- The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The...

CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN “MAGICAL-ISR” IDE STUDY IN THE US USA – English Middle East – English

TAMPA, Fla., April 19, 2024 /PRNewswire/ -- Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch – Sirolimus drug coated balloon (DCB), for the management of in-stent restenosis (ISR) in coronary...